Daniel C. Baumgart
Department of Medicine
Division of Gastroenterology and Hepatology
Charité Medical Centre
Virchow Hospital
Germany
Name/email consistency: high
- Crohn's disease. Baumgart, D.C., Sandborn, W.J. Lancet (2012)
- Endoscopic surveillance in Crohn's disease and ulcerative colitis: who needs what and when? Baumgart, D.C. Dig. Dis (2011)
- Anti-inflammatory effects of Saccharomyces boulardii mediated by myeloid dendritic cells from patients with Crohn's disease and ulcerative colitis. Thomas, S., Metzke, D., Schmitz, J., Dörffel, Y., Baumgart, D.C. Am. J. Physiol. Gastrointest. Liver Physiol. (2011)
- Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: Experience from a consecutive cohort of inflammatory bowel disease patients. Baumgart, D.C., Grittner, U., Steingräber, A., Azzaro, M., Philipp, S. Inflamm. Bowel Dis. (2011)
- IBD Around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010--Inflammatory Bowel Disease Task Force meeting. Baumgart, D.C., Bernstein, C.N., Abbas, Z., Colombel, J.F., Day, A.S., D'Haens, G., Dotan, I., Goh, K.L., Hibi, T., Kozarek, R.A., Quigley, E.M., Reinisch, W., Sands, B.E., Sollano, J.D., Steinhart, A.H., Steinwurz, F., Vatn, M.H., Yamamoto-Furusho, J.K. Inflamm. Bowel Dis. (2011)
- CB-01-05-MMX, a novel oral controlled-release low molecular weight heparin for the potential treatment of ulcerative colitis. Baumgart, D.C. Curr. Opin. Investig. Drugs (2010)
- Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis. Baumgart, D.C., Targan, S.R., Dignass, A.U., Mayer, L., van Assche, G., Hommes, D.W., Hanauer, S.B., Mahadevan, U., Reinisch, W., Plevy, S.E., Salzberg, B.A., Buchman, A.L., Mechkov, G.M., Krastev, Z.A., Lowder, J.N., Frankel, M.B., Sandborn, W.J. Inflamm. Bowel Dis. (2010)
- Transient cytokine-induced liver injury following administration of the humanized anti-CD3 antibody visilizumab (HuM291) in Crohn's disease. Baumgart, D.C., Lowder, J.N., Targan, S.R., Sandborn, W.J., Frankel, M.B. Am. J. Gastroenterol. (2009)
- The diagnosis and treatment of Crohn's disease and ulcerative colitis. Baumgart, D.C. Dtsch. Arztebl. Int (2009)
- Exaggerated inflammatory response of primary human myeloid dendritic cells to lipopolysaccharide in patients with inflammatory bowel disease. Baumgart, D.C., Thomas, S., Przesdzing, I., Metzke, D., Bielecki, C., Lehmann, S.M., Lehnardt, S., Dörffel, Y., Sturm, A., Scheffold, A., Schmitz, J., Radbruch, A. Clin. Exp. Immunol. (2009)
- Tacrolimus (FK506) for induction of remission in refractory ulcerative colitis. Baumgart, D.C., Macdonald, J.K., Feagan, B. Cochrane. Database. Syst. Rev (2008)
- What's new in inflammatory bowel disease in 2008?. Baumgart, D.C. World J. Gastroenterol. (2008)
- The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease. Baumgart, D.C., Buning, C., Geerdts, L., Schmidt, H.H., Genschel, J., Fiedler, T., Gentz, E., Molnar, T., Nagy, F., Lonovics, J., Lochs, H., Wiedenmann, B., Nickel, R., Witt, H., Dignass, A. Digestion (2007)
- Inflammatory bowel disease: clinical aspects and established and evolving therapies. Baumgart, D.C., Sandborn, W.J. Lancet (2007)
- Inflammatory bowel disease: cause and immunobiology. Baumgart, D.C., Carding, S.R. Lancet (2007)
- Virchow's node. Baumgart, D.C., Fischer, A. Lancet (2007)
- Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells. Baumgart, D.C., Metzke, D., Schmitz, J., Scheffold, A., Sturm, A., Wiedenmann, B., Dignass, A.U. Gut (2005)
- Successful recanalization of a completely obliterated esophageal stricture by using an endoscopic rendezvous maneuver. Baumgart, D.C., Veltzke-Schlieker, W., Wiedenmann, B., Hintze, R.E. Gastrointest. Endosc. (2005)
- Personal digital assistants in health care: experienced clinicians in the palm of your hand?. Baumgart, D.C. Lancet (2005)
- Current biological therapies for inflammatory bowel disease. Baumgart, D.C., Dignass, A.U. Curr. Pharm. Des. (2004)
- Intestinal barrier function. Baumgart, D.C., Dignass, A.U. Curr. Opin. Clin. Nutr. Metab. Care (2002)